Trial
NCT00167180
Post Transplant Donor Lymphocyte Infusion
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Masonic Cancer Center, University of Minnesota
Collaborators
—
Condition
Leukemia, Myeloid, Chronic
Intervention
Donor Lymphocyte Infusion
Why stopped
Accrual Goal Met
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-07-30